Chemed Corporation (CHE)

From the record

Chemed Corporation's filings since 2017 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Chemed Corporation's 10 filed years say what it did: revenue went from $1.6 billion in fiscal 2016 to $2.5 billion in fiscal 2025, up 5.4% a year; it rose in 8 of 9 years; the deepest fall was 0% from fiscal 2021 to fiscal 2022; net income was positive in 10 of 10 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Chemed Corporation's diluted share count shrank about 1.4% a year, and dividends and buybacks returned about 83% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 15 sales and 0 purchases of their own stock on the open market in the year to 2026-11-05 (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Chemed Corporation earned about 27 cents of profit for every dollar of shareholders' money, and gross profitability: its products earned about 54 cents per dollar of everything the company owns (revenue less the cost of revenue). Leverage: it owed about 36 cents per dollar of assets, and net share issuance: its share count shrank 4.8% over the year (the filed statements).

From the record

Chemed Corporation's standing among 22 graded names in its industry family: revenue of $2.5 billion in fiscal 2025 ranks in the bottom 34% by size; a net margin of 10.5% ranks in the top 7%; revenue growth of 5.8% a year over the last 3 filed years ranks in the bottom 30% (its annual reports).

From the record

Chemed Corporation's leadership, from its insiders' filings and its current reports: the chief executive on the record is Mcnamara, Kevin J (president and CEO, as filed), filing under that title since 2006-02-10, 20.8 years (top 3% of its family); the 14 officers and directors filing in the last fifteen months have been on the record a median of 10 years (top 14%); 3 officer or director changes were reported on Form 8-K since 2023-11-13, against the 14 people in charge now (top 11%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Chemed Corporation's room to grow, from the newest filed statements (fiscal 2025): cash of $75 million against no long-term debt tagged leaves 4.8% of its assets as net cash, top 12% of its family; cash from operations less capital spending is 12.9% of revenue (top 7%); a gross margin of 32.5% (top 25%) (its annual report).

From the record

Chemed Corporation's growth drivers, from the filed years to fiscal 2025: revenue grew 5.8% a year over the last three filed years against 5.4% over all 10, speeding up (bottom 39% of its family); the newest year grew 4.1% (bottom 25%); capital spending grew 3.1% a year (bottom 39%) (its annual reports). Chemed Corporation reported 2 lines of business in fiscal 2025: Segment Vitas at $1.6 billion (64%), Segment Roto Rooter at $900 million (36%); 1 of 2 grew against the year before (its annual report).

From the record

Chemed Corporation's newest year against its own record: revenue of $2.5 billion in fiscal 2025 came in 2.5% below the $2.6 billion its prior three years' pace pointed to (bottom 30% of its family); net income of $265 million against a prior three-year average of $275 million (bottom 20%); a net margin of 10.5% against 12% before (bottom 16%) (its annual reports).